NRC Council Member
Carolyn Cross is the Founder, Chairman and Chief Executive Officer of Ondine Biomedical Inc. and Sinuwave Technologies Corporation. She has over 30 years’ experience with public market securities and over 25 years’ experience working with early stage companies, with a background in finance, institutional investing and innovation. Earlier in her career, Ms. Cross was responsible for managing mutual funds, pension funds, pooled funds and discretionary private client portfolios as a Vice President with Royal Bank Investment Management Inc., the fund management arm of the Royal Bank of Canada.
Ms. Cross currently sits on a number of corporate boards including Greystone Capital Management Inc. and Cayoose Creek Development Ltd. (a First Nations company). She is a Board Member and Treasurer of the International Photodynamic Association (IPA) and Founder of the PanAmerican Photodynamic Association. Ms. Cross currently serves on the National Research Council of Canada, and is a past member of the Audit Committee and past Director of the Board of the Canada Foundation of Innovation (CFI).
She is a founding member of the Ernst & Young Global Women in Business Advisory Council, and Member of the Advisory Council of the World Health Innovation Network (WIN). She is a Founder, Chair and Board Member of the Women’s Economic Business Advisory Council. Ms. Cross is a Queen Elizabeth II Diamond Jubilee Award Recipient from the Government of Canada, and was awarded the Meritorious Service Cross by the Governor General of Canada (2016).
Ms. Cross holds a CFA designation, and MBA from York University, and an Honours in Business Administration from the University of Western Ontario.
- Date modified: